Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 2/20 | 0.32 |
| ▸ | BRD1 | O95696 | 1/20 | 0.32 |
| ▸ | TAF1 | P21675 | 1/20 | 0.32 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3768159 | 0.94 | TERT (0.35) | TERTCYP1B1TDP1 | |
| SCHEMBL13010687 | 0.90 | CYP1B1 (0.33) | TERTBRD1TAF1BRPF1CYP1B1 | |
| SCHEMBL17515105 | 0.90 | TERT (0.38) | TERTCYP1B1TDP1 | |
| SCHEMBL13010689 | 0.88 | CYP1B1 (0.32) | TERTBRD1TAF1BRPF1CYP1B1 | |
| SCHEMBL13010690 | 0.86 | SHMT2 (0.34) | CYP1B1 | |
| SCHEMBL13010693 | 0.85 | SHMT2 (0.38) | CYP1B1 | |
| SCHEMBL13010692 | 0.84 | CYP1B1 (0.34) | TERTBRD1TAF1BRPF1CYP1B1 | |
| SCHEMBL14817094 | 0.83 | KDM4E (0.31) | TERT | |
| SCHEMBL3781232 | 0.83 | CYP1B1 (0.37) | TERTCYP1B1TDP1 | |
| SCHEMBL13010679 | 0.82 | TERT (0.30) | TERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8404844-B2 | Perylene semiconductors and methods of preparation and use thereof | BASF SE (DE) | 2013-03-26 | — | — | US | disclosed |
| US-20100319778-A1 | PERYLENE SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2010-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100319778-A1 | PERYLENE SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF | CDYL, PNN, CPNE4 | TERT 1226/4885BRD1 3526/4885TAF1 1861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.